FHA
AGIO icon

First Horizon Advisors’s Agios Pharmaceuticals AGIO Stock Holding History

First Horizon Advisors’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$17.4K Sell
523
-21
-4% -$637 ﹤0.01% 1476
2025
Q1 		$15.9K Buy
544
+40
+8% +$1.33K ﹤0.01% 1425
2024
Q4 		$16.6K Sell
504
-3
-0.6% -$141 ﹤0.01% 1406
2024
Q3 		$22.5K Hold
507
– – ﹤0.01% 1311
2024
Q2 		$21.9K Sell
507
-81
-14% -$2.92K ﹤0.01% 1239
2024
Q1 		$17.2K Buy
588
+162
+38% +$4.34K ﹤0.01% 1388
2023
Q4 		$9.49K Buy
426
+20
+5% +$448 ﹤0.01% 1613
2023
Q3 		$10K Buy
406
+31
+8% +$820 ﹤0.01% 1508
2023
Q2 		$10.6K Buy
375
+54
+17% +$1.34K ﹤0.01% 1521
2023
Q1 		$7.37K Sell
321
-24
-7% -$637 ﹤0.01% 1676
2022
Q4 		$9.69K Buy
345
+27
+8% +$761 ﹤0.01% 1577
2022
Q3 		$9K Buy
318
+42
+15% +$1.13K ﹤0.01% 1533
2022
Q2 		$6K Buy
276
+109
+65% +$2.46K ﹤0.01% 1742
2022
Q1 		$5K Buy
167
+133
+391% +$4.06K ﹤0.01% 1278
2021
Q4 		$1K Buy
34
+22
+183% +$886 ﹤0.01% 2056
2021
Q3 		$0 Buy
+12
New +$580 ﹤0.01% 2264
2017
Q1 		– Sell
-56
Closed -$2K – 1468
2016
Q4 		$2K Hold
56
– – ﹤0.01% 1308
2016
Q3 		$2K Sell
56
-3
-5% -$131 ﹤0.01% 1299
2016
Q2 		$2K Hold
59
– – ﹤0.01% 1219
2016
Q1 		$2K Hold
59
– – ﹤0.01% 1242
2015
Q4 		$3K Sell
59
-30
-34% -$1.97K ﹤0.01% 1126
2015
Q3 		$6K Hold
89
– – ﹤0.01% 1116
2015
Q2 		$9K Buy
89
+3
+3% +$323 ﹤0.01% 1048
2015
Q1 		$8K Buy
+86
New +$9.64K ﹤0.01% 1098

Other funds holding AGIO

FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

First Horizon Advisors's AGIO Position: Q2 2025 in Review

First Horizon Advisors reduced its Agios Pharmaceuticals (AGIO) stake by 3.9% in Q2 2025, selling an estimated $637 and leaving 523 shares worth $17.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1476.

First Horizon Advisors first reported a position in AGIO in Q1 2015 and has held it in 24 quarters since. The position peaked at $22.5K in Q3 2024. 215 funds tracked by Wall St. Rank hold AGIO as of Q2 2025.

  • First Horizon Advisors held 523 shares of Agios Pharmaceuticals worth $17.4K as of Q2 2025.
  • First Horizon Advisors sold 21 Agios Pharmaceuticals shares in Q2 2025, an estimated $637.
  • Agios Pharmaceuticals made up ﹤0.01% of First Horizon Advisors's portfolio in Q2 2025, its #1476 holding.
  • First Horizon Advisors first reported a position in Agios Pharmaceuticals in Q1 2015 and has held it in 24 quarters since.
  • First Horizon Advisors's Agios Pharmaceuticals position peaked at $22.5K in Q3 2024.
  • 215 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2025.

Based on First Horizon Advisors's 13F filing for Q2 2025, filed 6 Aug 2025.